These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 30548742)

  • 21. Dipeptidyl Peptidase-4 Inhibitor Reduces the Risk of Developing Hypertrophic Scars and Keloids following Median Sternotomy in Diabetic Patients: A Nationwide Retrospective Cohort Study Using the National Database of Health Insurance Claims of Japan.
    Suwanai H; Watanabe R; Sato M; Odawara M; Matsumura H
    Plast Reconstr Surg; 2020 Jul; 146(1):83-89. PubMed ID: 32590649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids: A 2020 Update of the Algorithms Published 10 Years Ago.
    Ogawa R
    Plast Reconstr Surg; 2022 Jan; 149(1):79e-94e. PubMed ID: 34813576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining scar-modulating agents for the treatment of hypertrophic scars and keloids: A systematic review.
    Bernabe RM; Won P; Lin J; Pham C; Madrigal P; Yenikomshian H; Gillenwater TJ
    J Plast Reconstr Aesthet Surg; 2024 Jan; 88():125-140. PubMed ID: 37979279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intralesional Injection of Botulinum Toxin Type A Compared with Intralesional Injection of Corticosteroid for the Treatment of Hypertrophic Scar and Keloid: A Systematic Review and Meta-Analysis.
    Bi M; Sun P; Li D; Dong Z; Chen Z
    Med Sci Monit; 2019 Apr; 25():2950-2958. PubMed ID: 31006769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commentary on The Cellular Response of Keloids and Hypertrophic Scars to Botulinum Toxin A: A Comprehensive Literature Review.
    Carruthers A
    Dermatol Surg; 2018 Feb; 44(2):158. PubMed ID: 29309344
    [No Abstract]   [Full Text] [Related]  

  • 26. Alternative Clinical Indications of Botulinum Toxin.
    Alster TS; Harrison IS
    Am J Clin Dermatol; 2020 Dec; 21(6):855-880. PubMed ID: 32651806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intralesional treatment for keloids and hypertrophic scars: a review.
    Ledon JA; Savas J; Franca K; Chacon A; Nouri K
    Dermatol Surg; 2013 Dec; 39(12):1745-57. PubMed ID: 24299571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keloid and Hypertrophic Scars Are the Result of Chronic Inflammation in the Reticular Dermis.
    Ogawa R
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.
    Wolfram D; Tzankov A; Pülzl P; Piza-Katzer H
    Dermatol Surg; 2009 Feb; 35(2):171-81. PubMed ID: 19215252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research advances on the role and mechanism of inflammatory response in the formation of hypertrophic scars and keloids].
    Wang HT; Han JT; Hu DH
    Zhonghua Shao Shang Za Zhi; 2021 May; 37(5):490-494. PubMed ID: 34044530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of intralesional injection of botulinum toxin type A injection for hypertrophic scars.
    Elhefnawy AM
    Indian J Dermatol Venereol Leprol; 2016; 82(3):279-83. PubMed ID: 27088929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silicon gel sheeting for preventing and treating hypertrophic and keloid scars.
    O'Brien L; Pandit A
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003826. PubMed ID: 16437463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current Strategies in the Treatment of Scars and Keloids.
    Heppt MV; Breuninger H; Reinholz M; Feller-Heppt G; Ruzicka T; Gauglitz GG
    Facial Plast Surg; 2015 Aug; 31(4):386-95. PubMed ID: 26372714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keloids and Hypertrophic Scars Can Now Be Cured Completely: Recent Progress in Our Understanding of the Pathogenesis of Keloids and Hypertrophic Scars and the Most Promising Current Therapeutic Strategy.
    Ogawa R; Akaishi S; Kuribayashi S; Miyashita T
    J Nippon Med Sch; 2016; 83(2):46-53. PubMed ID: 27180789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on management of keloid and hypertrophic scars: A systemic review.
    Elsaie ML
    J Cosmet Dermatol; 2021 Sep; 20(9):2729-2738. PubMed ID: 34169622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt Signaling Pathway Proteins in Scar, Hypertrophic Scar, and Keloid: Evidence for a Continuum?
    Chaudet KM; Goyal A; Veprauskas KR; Nazarian RM
    Am J Dermatopathol; 2020 Nov; 42(11):842-847. PubMed ID: 32310858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of botulinum toxin type A in the prevention and treatment of facial hypertrophic scars: A meta-analysis.
    Lin J; Wang X
    Int Wound J; 2024 Mar; 21(3):e14796. PubMed ID: 38494191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Topical Preparations for Prevention and Treatment of Hypertrophic Scars and Keloids: A Literature Review].
    Fischer S; Ernst HR; Drücke D; Diehm Y; Lehnhardt M; Daigeler A
    Handchir Mikrochir Plast Chir; 2015 Aug; 47(4):253-67. PubMed ID: 26075896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Letter to the Editor: Evaluation of Efficacy of Corticosteroid and Corticosteroid Combined with Botulinum Toxin Type A in the Treatment of Keloid and Hypertrophic Scars-A Meta-Analysis.
    Yue S; Ju M
    Aesthetic Plast Surg; 2022 Aug; 46(4):2095-2096. PubMed ID: 34462795
    [No Abstract]   [Full Text] [Related]  

  • 40. A systematic review of the efficacy, safety and satisfaction of regenerative medicine treatments, including platelet-rich plasma, stromal vascular fraction and stem cell-conditioned medium for hypertrophic scars and keloids.
    Jafarzadeh A; PourMohammad A; Goodarzi A
    Int Wound J; 2024 Apr; 21(4):e14557. PubMed ID: 38126221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.